Portal de Periódicos da CAPES

The Abrupt Discontinuation of Antihypertensive Treatment

1979; Wiley; Volume: 19; Issue: 8-9 Linguagem: Inglês

10.1002/j.1552-4604.1979.tb02510.x

1552-4604

STANLEY B. GARBUS, Michael A. Weber, Richard T. Priest, Deborah D. Brewer, F. Allan Hubbell,

Hormonal Regulation and Hypertension

The Journal of Clinical PharmacologyVolume 19, Issue 8-9 p. 476-486 The Abrupt Discontinuation of Antihypertensive Treatment STANLEY B. GARBUS M.D., STANLEY B. GARBUS M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this authorDr. MICHAEL A. WEBER M.D., Corresponding Author Dr. MICHAEL A. WEBER M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Hypertension Center, Veterans Administration Medical Center, 5901 East Seventh Street, Long Beach, Cal. 90822.Search for more papers by this authorRICHARD T. PRIEST M.D., RICHARD T. PRIEST M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this authorDEBORAH D. BREWER B.S., DEBORAH D. BREWER B.S. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this authorF. ALLAN HUBBELL M.D., F. ALLAN HUBBELL M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this author STANLEY B. GARBUS M.D., STANLEY B. GARBUS M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this authorDr. MICHAEL A. WEBER M.D., Corresponding Author Dr. MICHAEL A. WEBER M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Hypertension Center, Veterans Administration Medical Center, 5901 East Seventh Street, Long Beach, Cal. 90822.Search for more papers by this authorRICHARD T. PRIEST M.D., RICHARD T. PRIEST M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this authorDEBORAH D. BREWER B.S., DEBORAH D. BREWER B.S. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this authorF. ALLAN HUBBELL M.D., F. ALLAN HUBBELL M.D. Hypertension Center, Veterans Administration Medical Center of Long Beach, and the University of California, Irvine, Cal.Search for more papers by this author First published: August‐September 1979 https://doi.org/10.1002/j.1552-4604.1979.tb02510.xCitations: 29AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Phillips, P. J., Bastian, P. D., Burrow, D. D., Henschke, P. H., and Waltham, R. D.: Drug-withdrawal syndromes. Lancet 1: 1131 (1976). 10.1016/S0140-6736(76)99023-1 CASPubMedWeb of Science®Google Scholar 2 Vaisrub, S.: Pulling the therapeutic rug. J.A.M.A. 239: 2277 (1978). 10.1001/jama.1978.03280480069028 CASPubMedWeb of Science®Google Scholar 3 Roussounis, S. H.: Benign intracranial hypertension after withdrawal of topical steroids in an infant. Brit. Med. J. 2: 564 (1976). 10.1136/bmj.2.6035.564 CASPubMedWeb of Science®Google Scholar 4 Hargreave, F. E., McCarthy, D. S., and Pepys, J.: Steroid “pseudorheumatism” in asthma. Brit. Med. J. 1: 443 (1969). 10.1136/bmj.1.5641.443-b PubMedWeb of Science®Google Scholar 5 Michaels, L., and Beamish, R. E.: Relapses of thromboembolic disease after discontinued anticoagulant therapy. Amer. J. Cardiol. 20: 670 (1967). 10.1016/0002-9149(67)90010-0 CASPubMedWeb of Science®Google Scholar 6 Editorial: Rebound thrombosis after stopping anticoagulants. Brit. Med. J. 2: 1343 (1966). 10.1136/bmj.2.5526.1343-a Google Scholar 7 Hughes, R. D., Polgar, J. G., Weightman, D., and Walton, J. N.: Levodopa in parkinsonism: the effects of withdrawal of anticholinergic drugs. Brit. Med. J. 2: 487 (1971). 10.1136/bmj.2.5760.487 CASPubMedWeb of Science®Google Scholar 8 Woodbury, D. M.: Analgesic—antipyretics, anti-inflammatory agents, and inhibitors of uric acid synthesis. In The Pharmacological Basis of Therapeutics, L. S. Goodman, and A. Gilman, Eds. New York, MacMillan, 1970, pp. 314–347. Google Scholar 9 Moser, M., and Wood, D.: Management of hypertension. J.A.M.A. 235: 2297 (1967). 10.1001/jama.235.21.2297 PubMedWeb of Science®Google Scholar 10 Mroczek, W. J., and Davidov, M. E.: Rebound hypertension after withdrawal of antihypertensive therapy. Clin. Ree. 26: 622A (1978). Google Scholar 11 Cannon, P. J., Whitlock, R. T., Morris, R. C., Angers, M., and Laragh, J. H.: Effect of alpha-methyl DOPA in severe and malignant hypertension. J.A.M.A. 179: 673 (1962). 10.1001/jama.1962.03050090001001 CASPubMedWeb of Science®Google Scholar 12 Horwitz, D., Pettinger, W. A., Orvis, H., Thomas, R. E., and Sjoerdsma, A.: Effects of methyldopa in fifty hypertensive patients. Clin. Pharmacol. Therap. 8: 224 (1967). 10.1002/cpt196782224 CASPubMedWeb of Science®Google Scholar 13 Burden, A. C., and Alexander, C. P. T.: Rebound hypertension after acute methyldopa withdrawal. Brit. Med. J. 1: 1056 (1976). 10.1136/bmj.1.6017.1056 CASPubMedWeb of Science®Google Scholar 14 Scott, J. N., and McDevitt, D. G.: Rebound hypertension after acute methyldopa withdrawal. Brit. Med. J. 2: 367 (1976). 10.1136/bmj.2.6031.367-b CASPubMedWeb of Science®Google Scholar 15 Frewin, D. B., and Penhall, R. K.: Rebound hypertension after sudden discontinuation of methyldopa therapy. Med. J. Austr. 1: 659 (1977). 10.5694/j.1326-5377.1977.tb130994.x CASPubMedWeb of Science®Google Scholar 16 Hansson, L., Hunyor, S. N., Julius, S., and Hoobler, S.W.: Blood pressure crisis following withdrawal of clonidine, with special reference to arterial and urinary catecholamine levels, and suggestions for acute management. Amer. Heart J. 85: 605 (1973). 10.1016/0002-8703(73)90165-8 CASPubMedWeb of Science®Google Scholar 17 Hunyor, S. N., Hansson, L., Harrison, T. S., and Hoobler, S. W.: Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Brit. Med. J. 2: 209 (1973). 10.1136/bmj.2.5860.209 CASPubMedWeb of Science®Google Scholar 18 Goldberg, A. D., Raftery, E. B., and Wilkinson, P.: Blood pressure and heart rate and withdrawal of antihypertensive drugs. Brit. Med. J. 1: 1243 (1977). 10.1136/bmj.1.6071.1243 CASPubMedWeb of Science®Google Scholar 19 Stelzer, F. P., Stubenbord, J. J., Sreenivasan, V., and Venuto, R. C.: Late toxicity of clonidine withdrawal. New England J. Med. 294: 1182 (1976). 10.1056/NEJM197605202942116 CASPubMedWeb of Science®Google Scholar 20 Frolich, J. C.: Symptoms of clonidine withdrawal after 17 days. New England J. Med. 295: 1261 (1976). 10.1056/NEJM197611252952220 CASPubMedWeb of Science®Google Scholar 21 Webster, J., Jeffers, A., Galloway, D. B., and Petrie, J. C.: Withdrawal of antihypertensive therapy. Lancet 2: 1381 (1974). 10.1016/S0140-6736(74)92246-6 CASPubMedWeb of Science®Google Scholar 22 Strauss, F. D., Franklin, S. S., Lewin, A. J., and Maxwell, M. H.: Withdrawal of antihypertensive therapy, hypertensive crisis in renovascular hypertension. J.A.M.A. 238: 1734 (1977). 10.1001/jama.1977.03280170028020 CASPubMedWeb of Science®Google Scholar 23 Brodsky, J. B., and Bravo, J. J.: Acute postoperative clonidine withdrawal syndrome. Anesthesiology 44: 519 (1976). 10.1097/00000542-197606000-00009 CASPubMedWeb of Science®Google Scholar 24 Dinon, L. R., Kim, Y. S., and Vander, Vander J. B.: Clinical experience with chlorothiazide (Diuril) with particular emphasis on untoward responses: a report of 121 cases studied over a 15-month period. Amer. J. Med. Sci. 236: 533 (1958). CASPubMedWeb of Science®Google Scholar 25 Gal, T. J., and Cooperman, L. H.: Hypertension in the immediate postoperative period. Brit. J. Anaesth. 47: 70 (1975). 10.1093/bja/47.1.70 CASPubMedWeb of Science®Google Scholar 26 Reid, J. L., Dargie, H. L., Davies, D. S., Wing, L. M. H., Hamilton, C. A., and Dollery, C. T.: Clonidine withdrawal in hypertension. Lancet 1: 1171 (1977). 10.1016/S0140-6736(77)92715-5 CASPubMedWeb of Science®Google Scholar 27 Bailey, R. R., and Neale, T. J.: Rapid clonidine withdrawal with blood pressure over-shoot exaggerated by beta-blockade. Brit. Med. J. 1: 942 (1976). 10.1136/bmj.1.6015.942-a CASPubMedWeb of Science®Google Scholar 28 Hoobler, S. W., and Kashima, T.: Central nervous system actions of clonidine in hypertension. Mayo Clin. Proc. 52: 395 (1977). CASPubMedWeb of Science®Google Scholar 29 Whitsett, T. L.: Abrupt cessation of clonidine administration: a prospective study. Amer. J. Cardiol. 41: 1285 (1978). 10.1016/0002-9149(78)90887-1 CASPubMedWeb of Science®Google Scholar 30 Whitsett, T. L.: Discontinuation of clonidine therapy. In Fifth Hahnemann International Symposium on Hypertension. Hypertension: Detriments, Complications and Intervention—1977, G. Onesti, et al., Eds. New York, Grune and Stratton, 1978. Google Scholar 31 Ram, C. V. S., Holland, O. B., Fairchild, C., and Gomez-Sanchez, C. E.: Withdrawal syndrome following cessation of guanabenz therapy. J. Clin. Pharmacol. 19: 148 (1979). 10.1002/j.1552-4604.1979.tb02472.x CASPubMedWeb of Science®Google Scholar 32 Hess, S. M., and Connamacher, R. H.: The effects of alpha-methyldopa and alpha-methyl-meta-tyrosine on the metabolism of norepinephrine and serotonin in vivo. J. Pharmacol. Exp. Therap. 134: 129 (1961). CASPubMedWeb of Science®Google Scholar 33 Kobinger, W.: Pharmacologic basis of the cardiovascular actions of clonidine. In Hypertension: Mechanims and Management, G. Onesti, et al., Eds. New York, Grune and Stratton 1973, p. 369. Google Scholar 34 Hokfelt, B., Hedeland, H., and Dymling, J. F.: Studies on catecholamines, renin and aldosterone following Catapresan in hypertensive patients. Europ. J. Pharmacol. 10: 389 (1970). 10.1016/0014-2999(70)90212-8 CASPubMedWeb of Science®Google Scholar 35 Goldberg, A. D., Wilkinson, P. R., and Raftery, E. B.: The over-shoot phenomenon on withdrawal of clonidine therapy. Postgrad. Med. J. 52: 128 (1976). PubMedWeb of Science®Google Scholar 36 Weber, M. A., Case, D. B., Baer, L., Sealey, J. E., Drayer, J. I. M., Lopez-Ovejero, J. A., and Laragh, J. H.: Renin and aldosterone suppression in the antihypertensive action of clonidine. Amer. J. Cardiol. 38: 825 (1976). 10.1016/0002-9149(76)90361-1 CASPubMedWeb of Science®Google Scholar 37 Weidmann, P., Hirsch, D., and Maxwell, M. H.: Plasma renin and blood pressure during treatment with methyldopa. Amer. J. Cardiol. 34: 671 (1974). 10.1016/0002-9149(74)90156-8 CASPubMedWeb of Science®Google Scholar 38 Stokes, G. S., Weber, M. A., Thornell, I. R., Stoker, L. M., and Sebel, E. F.: Effects of acute and chronic administration of propranolol on blood pressure and plasma renin activity in hypertensive patients. In Drugs and the Kidney, D. E. Edwards, Ed. Basel, Karger, 1974, pp. 29–44. Google Scholar 39 Stokes, G. S., Weber, M. A., and Thornell, I. R.: Beta-blockers and plasma renin activity in hypertension. Brit. Med. J. 1: 60 (1974). 10.1136/bmj.1.5897.60 CASPubMedWeb of Science®Google Scholar 40 Castenfors, J., Johnsson, H., and Oro, L.: Effect of alprenolol on blood pressure and plasma renin activity in hypertensive patients. Acta Med. Scand. 193: 189 (1973). 10.1111/j.0954-6820.1973.tb10560.x CASPubMedWeb of Science®Google Scholar 41 Morgan, T., Carney, S., and Roberts, R.: Changes in plasma renin activity and blood pressure after acute and chronic administration of beta-adrenergic receptor blocking drugs. Clin. Sci. Mol. Med. 48 (Suppl. 2): 81 (1975). Google Scholar 42 O'Brien, E. T., and Mackinnon, J.: Propranolol and polythiazide in treatment of hypertension. Brit. Heart J. 34: 1042 (1972). 10.1136/hrt.34.10.1042 CASPubMedWeb of Science®Google Scholar 43 Pederson, O. L.: Comparison of metoprolol and hydrochlorothiazide as antihypertensive agents. Europ. J. Clin. Pharmacol. 10: 381 (1976). 10.1007/BF00563073 Google Scholar 44 Shenkman, L., Podrid P., and Lowenstein, J.: Hyperthyroidism after propranolol withdrawal. J.A.M.A. 238: 237 (1977). 10.1001/jama.1977.03280030045021 CASPubMedWeb of Science®Google Scholar 45 Kristensen, B. O., Steiness, E., and Weeke, J.: Propranolol withdrawal and thyroid hormones in patients with essential hypertension. Clin. Pharmacol. Therap. 23: 624 (1978). 10.1002/cpt1978236624 CASPubMedWeb of Science®Google Scholar 46 Alderman, E. L., Coltart, D. J., Wettach, G. E., and Harrison, D. C.: Coronary artery syndromes after sudden propranolol withdrawal. Ann. Int. Med. 81: 625 (1974). 10.7326/0003-4819-81-5-625 CASPubMedWeb of Science®Google Scholar 47 Slome, R.: Withdrawal of propranolol and myocardial infarction. Lancet 1: 156 (1973). 10.1016/S0140-6736(73)90235-3 CASPubMedWeb of Science®Google Scholar 48 Zsoter, T. T., and Beanlands, D. S.: Propranolol in angina pectoris. Arch. Int. Med. 124: 584 (1969). 10.1001/archinte.1969.00300210066009 CASPubMedWeb of Science®Google Scholar 49 Miller, R. R., Olson, H. G., Amsterdam, E. A., and Mason, D. T.: Propranolol withdrawal rebound phenomenon. New England J. Med. 239: 416 (1975). 10.1056/NEJM197508282930902 Web of Science®Google Scholar 50 Editorial: Beta-blockade withdrawal Lancet 1: 592 (1975). PubMedWeb of Science®Google Scholar 51 Whelton, P. K., Flaherty, J. T., MacAllister, N. P., Potter, A., Johnson, D., Watkins, L., Russell, R. P., and Walker, W. G.: Propranolol withdrawal in the pathogenesis of hypertension following coronary artery bypass surgery. In Proc. Int. Soc. Hypertension (Paris), 1978, p. 295. Google Scholar 52 Diaz, R. G., Somberg, J. C., Freeman, E., and Levitt, B.: Myocardial infarction after propranolol withdrawal. Amer. Heart J. 88: 257 (1974). 10.1016/0002-8703(74)90019-2 CASPubMedWeb of Science®Google Scholar 53 Frishman, W. H., Christodoulou, J., Weksler, B., Smithen, C., Killip, T., and Scheidt, S.: Abrupt propranolol withdrawal in angina pectoris: effects on platelet aggregation and exercise tolerance. Amer. Heart J. 95: 169 (1978). 10.1016/0002-8703(78)90460-X CASPubMedWeb of Science®Google Scholar 54 Buhler, F. R., Laragh, J. H., Baer, L., Vaughan, D. E., and Brunner, H. R.: Propranolol inhibition of renin secretion: a specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. New England J. Med. 287: 1209 (1972). 10.1056/NEJM197212142872401 PubMedWeb of Science®Google Scholar 55 Hollifield, J., Sherman, K., and Shand, D.: Propranolol's proposed dual antihypertensive activity. Circulation 52 (Suppl. 2): 98 (1975). Google Scholar 56 Shand, D. G.: Propranolol withdrawal. New England J. Med. 293: 449 (1975). 10.1056/NEJM197508282930910 CASPubMedWeb of Science®Google Scholar 57 Buhler, F. R., Laragh, J. H., Vaughan, E. D., Brunner, H. R., Gavras, H., and Baer, L.: Antihypertensive action of propranolol. Amer. J. Cardiol. 32: 511 (1973). 10.1016/S0002-9149(73)80043-8 PubMedWeb of Science®Google Scholar 58 Boudoulas, H., Lewis, R. P., Kates, R. E., and Dalamangas, G.: Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects. Ann. Int. Med. 87: 433 (1977). 10.7326/0003-4819-87-4-433 CASPubMedWeb of Science®Google Scholar 59 Ruch, T. C., and Patton, H. D.: Physiology and Biophysics. Philadelphia, Saunders, 1965, p. 235. Google Scholar 60 Dustan, H. P., Page, I. H., Tarazi, R. C., and Frohlich, E. D.: Arterial pressure responses to discontinuing antihypertensive drugs. Circulation 37: 370 (1968). 10.1161/01.CIR.37.3.370 PubMedWeb of Science®Google Scholar 61 MacGregor, G. A., Tasker, P. R. W., and de Wardener, H. E.: Diuretic-induced edema. Lancet 1: 489 (1975). 10.1016/S0140-6736(75)92833-0 CASPubMedWeb of Science®Google Scholar 62 Keim, H. J., Drayer, J. I., Case, D. B., Lopez-Ovejero, J., Wallace, J. M., Weber, M. A., and Laragh, J. H.: A role for renin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar1-Ala8-angiotensin II). New England J. Med. 295: 1175 (1976). 10.1056/NEJM197611182952106 CASPubMedWeb of Science®Google Scholar 63 Chrysant, S. G., and Whitsett, T. L.: Withdrawal of antihypertensive therapy. J.A.M.A. 239: 2241 (1978). 10.1001/jama.1978.03280480033011 CASPubMedWeb of Science®Google Scholar 64 Weber, M. A.: Blood pressure rebound following withdrawal of antihypertensive treatment. J.A.M.A. 239: 833 (1978). 10.1001/jama.1978.03280360029010 CASPubMedWeb of Science®Google Scholar 65 Burkhalter, J. F., Franklin, S. S., Maxwell, M. H., and Lupu, A. N.: Influence of posture and sodium balance on plasma catecholamines in normal subjects and in patients with essential and renovascular hypertension. In Proc. 11th Ann. Mtgs. Amer. Soc. Nephrology (New Orleans), 1978, p. 58A. Google Scholar Citing Literature Volume19, Issue8-9August‐September 1979Pages 476-486 ReferencesRelatedInformation